BPC-157 for Lyme Disease Research — Clinical Evidence Research from the University of Zagreb found that BPC-157 (Body Protection Compound-157) demonstrated neuroprotective properties in animal models of neuroinflammatio…
BPC-157 for Lyme Disease Researchers — Current Evidence A 2024 animal study from the University of Zagreb found that BPC-157 (body protection compound-157) accelerated nerve regeneration by 40% in models of peripheral n…
Thymosin Alpha-1 BPC-157 for Lyme Research | Real Peptides Researchers at Stanford's Lyme Disease Research Program documented a pattern in 2024 that shifted how the field thinks about chronic Lyme treatment: patients wi…